The future of outsourcing: Live from J.P. Morgan Week

Less than 1 min read
Scroll

In the latest episode of Molecule to Market, host Raman Sehgal takes you inside the evolving outsourcing landscape of the global drug development sector in a conversation with our Executive Vice President, Dean McAlister. Together, they explore critical insights shaping the pharmaceutical and biotechnology supply chain, including:

  • The shifting dynamics within the life sciences sector and their influence on outsourcing strategies.
  • Key takeaways from J.P. Morgan Week, highlighting challenges and opportunities for CROs and CDMOs.
  • The impact of cautious optimism on business development teams and commercial strategies in today’s market.
  • Why 2025 is expected to be a year of incremental growth—and how contract service providers can navigate market headwinds to drive success.
  • The strategic importance of customer engagement and brand positioning for specialized players looking to compete with global CDMO giants.

“Innovation wins—innovation will find a way to the marketplace, and the marketplace finds a way to reward innovation.” – Dean McAlister, Executive Vice President, Inizio

Tune in to gain valuable perspectives on how the industry is adapting and what lies ahead for outsourcing in drug development. Access the podcast episode here.